Replies to post #171680 on Biotech Values

[mcbio]

Xofigo may not be sexy, but it works! The clinical data in CRPC match up pretty well against the competition and there are opportunities for combination therapy.

Yeah but can a radiotherapy generate enough in sales to offer decent upside from ~$3B purchase price? Bayer could have acquired all nine of the companies I own shares in for about $2B (assuming no premium). May speak more to the quality of the companies I invest in. LOL